Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies-Reference-Cited by-同舟云学术

Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies

Published:2018-12-04 Issue:5 Volume:234 Page:5655-5663
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Mahdi Ali¹,Darvishi Behrad¹,Majidzadeh‐A Keivan¹²^ORCID,Salehi Malihe¹,Farahmand Leila¹

Affiliation:

1. Department of Recombinant Proteins Breast Cancer Research Center, Motamed Cancer Institute, ACECR Tehran Iran

2. Tasnim Biotechnology Research Center, Faculty of Medicine, AJA University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27414

Reference98 articles.

1. Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

2. Critical Role of Hypoxia Sensor - HIF-1α in VEGF Gene Activation. Implications for Angiogenesis and Tissue Injury Healing

3. Making sense of low oxygen sensing

4. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer

5. Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorinated Cell-Penetrating Peptide for Co-Delivering siHIF-1α and Sorafenib to Enhance In Vitro Anti-Tumor Efficacy;Pharmaceutics;2023-12-16

2. Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation;International Journal of Oncology;2023-08-10

3. Emerging role of interactions between tumor angiogenesis and cancer stem cells;Journal of Controlled Release;2023-08

4. OTUB1 Catalytic-Independently Deubiquitinates TGFBI and Mediates the Angiogenesis in Infantile Hemangioma by Regulating Glycolysis;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-05

5. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells;BMB Reports;2023-01-31